Kazuhide Oshiden

Presence of epidermal growth factor in human tears.

Yuichi Ohashi, M Motokura, Yoshihisa Kinoshita et al. · PubMed · 1989 · 215 citations

Medicine, Ophthalmology, Ocular Pathology +4

Rebamipide (OPC-12759) in the Treatment of Dry Eye: A Randomized, Double-Masked, Multicenter, Placebo-Controlled Phase II Study

Shigeru Kinoshita, Saki Awamura, Kazuhide Oshiden et al. · Ophthalmology · 2012 · 146 citations · Full text

Medicine, Ophthalmology, Pharmacology +11

A Randomized, Multicenter Phase 3 Study Comparing 2% Rebamipide (OPC-12759) with 0.1% Sodium Hyaluronate in the Treatment of Dry Eye

Shigeru Kinoshita, Kazuhide Oshiden, Saki Awamura et al. · Ophthalmology · 2013 · 143 citations

Medicine, Ophthalmology, Pharmacotherapy +11

A Multicenter, Open-Label, 52-Week Study of 2% Rebamipide (OPC-12759) Ophthalmic Suspension in Patients With Dry Eye

Shigeru Kinoshita, Saki Awamura, Norihiro Nakamichi et al. · American Journal of Ophthalmology · 2013 · 71 citations

Medicine, Ophthalmology, Pharmacology +16

Phase 2, randomized, double‐blind, placebo‐controlled, 4‐week study to evaluate the safety and efficacy of OPA‐ 15406 (difamilast), a new topical selective phosphodiesterase type‐4 inhibitor, in Japanese pediatric patients aged 2–14 years with atopic dermatitis

Hidehisa Saeki, Naoko Baba, Kazuhide Oshiden et al. · The Journal of Dermatology · 2019 · 39 citations · Full text

Medicine, Dermatology, Pharmacology +14